NF-κB: blending metabolism, immunity, and inflammation
Open accessAbstract
The procurement and management of nutrients and ability to fight infections are fundamental requirements for survival. These defense responses are bioenergetically costly, requiring the immune system to balance protection against pathogens with the need to maintain metabolic homeostasis. NF-κB transcription factors are central regulators of immunity and inflammation. Over the last two decades, these factors have emerged as a pivotal node coordinating the immune and metabolic systems in physiology and the etiopathogenesis of major threats to human health, including cancer, autoimmunity, chronic inflammation, and others. In this review, we discuss recent advances in understanding how NF-κB-dependent metabolic programs control inflammation, metabolism, and immunity and how improved knowledge of them may lead to better diagnostics and therapeutics for widespread human diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NF-κB is activated by various stimuli, including TLR4 ligands and cytokines such as CD40, TNF-α, IL-1β, and BAFF within the bone marrow microenvironment.
“NF-κB is activated by various stimuli, including Toll-like receptor 4 (TLR4) ligands and cytokines such as CD40, TNF-α, IL-1β, and B-cell activating factor (BAFF) within the bone marrow microenvironment.”
From Multiple myeloma: signaling pathways and targeted therapy (2024) · cites this paper as [136]
NF-κB is a pivotal transcription factor implicated in MM pathogenesis, particularly in the bone marrow microenvironment.
“NF-κB is a pivotal transcription factor implicated in MM pathogenesis, particularly in the bone marrow microenvironment.”
From Multiple myeloma: signaling pathways and targeted therapy (2024) · cites this paper as [136]
NF-κB signaling is categorized into canonical and non-canonical pathways; the canonical pathway involves p50-RelA complexes regulated by IKKα, β, and γ, while the non-canonical pathway involves p52-RelB complexes regulated by IKKα.
“NF-κB signaling is categorized into canonical and non-canonical pathways. In the canonical pathway, NF-κB1 (p50)-RelA (p65) complexes are activated and regulated by a trimeric complex consisting of IκB kinases (IKK) α, β, and γ. Conversely, the non-canonical pathway involves NF-κB2 (p52)-RelB complexes, regulated by a dimeric complex of IKKα [136, 137] (Fig. 1).”
From Multiple myeloma: signaling pathways and targeted therapy (2024) · cites this paper as [136]
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932 · see citing works
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172 · see citing works
Nutrient sensing and inflammation in metabolic diseases
Hotamisligil, G. S., & Erbay, E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2449 · Cited by 1,040 · see citing works
Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB
Catrysse, L., & van Loo, G. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.01.006 · Cited by 329 · see citing works
c-Rel gain in B cells drives germinal center reactions and autoantibody production
Kober-Hasslacher, M., Oh-Strauß, H., Kumar, D., Soberon, V., Diehl, C., Lech, M., Engleitner, T., Katab, E., Fernández-Sáiz, V., Piontek, G., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci124382 · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Drug repurposing for cancer therapy
Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443 · see citing works
Protein neddylation and its role in health and diseases
Zhang, S., Yu, Q., Li, Z., Zhao, Y., & Sun, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01800-9 · Cited by 171 · see citing works
Multiple myeloma: signaling pathways and targeted therapy
Lu, Q., Yang, D., Li, H., Niu, T., & Tong, A. (2024) · Molecular biomedicine · doi:10.1186/s43556-024-00188-w · Cited by 90 · see citing works
Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells
Cippitelli, M., Stabile, H., Kosta, A., Petillo, S., Lucantonio, L., Gismondi, A., Santoni, A., & Fionda, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031823 · Cited by 26 · see citing works
- Authors
- Capece, D., Verzella, D., Flati, I., Arboretto, P., Cornice, J., & Franzoso, G.
- Affiliations
- University of L'Aquila (IT)
- Imperial College London (GB)
- Corresponding author
- Capece, Daria
- Franzoso, Guido
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 43
- Issue
- 9
- Pages
- 757-775
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W4291000418
- Cited by
- 538
- References
- 6
- Citations by year
- 2026: 109 · 2025: 169 · 2024: 162 · 2023: 89 · 2022: 9
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Trends in Immunology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion, cc-by)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Medical Research Council (MR/V027581/1, 07_DG_2022_02)
- Cancer Research UK (C26587/A8839)
- Compagnia di San Paolo
- NIHR Imperial Biomedical Research Centre (P81135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NF-κB, metabolism, immunity, inflammation, immune-metabolic crosstalk, nutrient sensing, energy homeostasis, chronic inflammation, autoimmunity, cancer, transcription factors
- MeSH terms
- Homeostasis, Humans, Inflammation, Neoplasms, Autoimmunity, NF-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review